Clinical Trial Update: Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating intra-articular DLX105 for severely painful knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• DLX105

Snippet

Sponsor: ESBATech AG | Conditions: Osteoarthritis | Phase 1, Phase 2 | Status: COMPLETED